Canadian study OKs Losec and Nexium

Feb 27, 2008

Health Canada has completed a review of safety information for Losec (omeprazole) and Nexium (esomeprazole) and found no increased cardiovascular risks.

Both prescription drugs are used to treat conditions in which a reduction of gastric acid secretion is required, such as ulcers and reflux.

In Canada, omeprazole is also sold in generic form as Apo-omeprazole, Ratio-omeprazole and Sandoz-omeprazole. Esomeprazole is only sold under the trade name Nexium.

Based on its review, Health Canada scientists said they found no evidence supporting an increased cardiovascular risk associated with the long-term use of either drug.

Officials advised patients taking either Losec or Nexium to not make any changes to their medication unless they first discuss it with their physicians.

Copyright 2008 by United Press International

Explore further: Bristol-Myers: FDA blocks hepatitis C drug for now

add to favorites email to friend print save as pdf

Related Stories

Mysterious glowworm found in Peruvian rainforest

43 minutes ago

(Phys.org) —Wildlife photographer Jeff Cremer has discovered what appears to be a new type of bioluminescent larvae. He told members of the press recently that he was walking near a camp in the Peruvian ...

Recommended for you

Have a cold? Don't ask your doctor for antibiotics

Nov 26, 2014

Antibiotic resistance is a major threat to public health. Resistance makes it harder for physicians to treat infections and can increase the chance patients will die from an infection. What is more, the treatment ...

Powdered measles vaccine found safe in early clinical trials

Nov 25, 2014

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.